8-K
Current Report
AIM ImmunoTech Inc. Filed Acc 0001615774-16-003899
Agreement ended · Executive or director change
- Item 1.02 Termination of a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading s102488_8k.htm…